Phio Pharmaceuticals (PHIO) Revenue (2012 - 2019)
Phio Pharmaceuticals' (PHIO) quarterly Revenue came in at $21000.0 in Q1 2019, down 8.7% YoY from $23000.0 in Q1 2018, and down 63.16% on a QoQ basis from $57000.0 in Q3 2018.
Phio Pharmaceuticals (PHIO) Revenue (2012 - 2019) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 8 years of Revenue data on file, last reported at $21000.0 in Q1 2019.
- Quarterly Revenue fell 8.7% year-over-year to $21000.0 in Q1 2019, while the trailing twelve-month figure through Dec 2019 was $21000.0 (down 84.78% YoY) and the FY2019 annual result came in at $21000.0, down 84.78% from the prior year.
- Revenue fell to $21000.0 in Q1 2019, from $57000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $58000.0 in Q2 2018 to a low of $9000.0 in Q2 2016.
- A 5-year average of $28375.0 and a median of $22000.0 in 2018 frame the typical range for Revenue.
- Annual changes were most pronounced in 2015 — Revenue grew 17.24% — and 2016, when it sank 70.59%.
- Tracing PHIO's Revenue over 5 years: stood at $34000.0 in 2015, then sank by 73.53% to $9000.0 in 2016, then soared by 66.67% to $15000.0 in 2017, then surged by 280.0% to $57000.0 in 2018, then sank by 63.16% to $21000.0 in 2019.
- The last three Revenue figures came in at $21000.0 (Q1 2019), $57000.0 (Q3 2018), and $58000.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 21,000.00 |
| Sep 30, 2018 | 57,000.00 |
| Jun 30, 2018 | 58,000.00 |
| Mar 31, 2018 | 23,000.00 |
| Dec 31, 2017 | 15,000.00 |
| Jun 30, 2016 | 9,000.00 |
| Mar 31, 2016 | 10,000.00 |
| Mar 31, 2015 | 34,000.00 |
| Dec 31, 2014 | 14,000.00 |
| Sep 30, 2014 | 16,000.00 |
| Jun 30, 2014 | 12,000.00 |
| Mar 31, 2014 | 29,000.00 |
| Dec 31, 2013 | 29,000.00 |
| Sep 30, 2013 | 92,000.00 |
| Jun 30, 2013 | 225,000.00 |
| Mar 31, 2013 | 53,000.00 |
| Dec 31, 2012 | 40,000.00 |
| Sep 30, 2012 | 57,000.00 |